Weijian Sun

2.1k total citations · 1 hit paper
84 papers, 1.6k citations indexed

About

Weijian Sun is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Weijian Sun has authored 84 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 27 papers in Biomedical Engineering and 15 papers in Oncology. Recurrent topics in Weijian Sun's work include Nanoplatforms for cancer theranostics (16 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Weijian Sun is often cited by papers focused on Nanoplatforms for cancer theranostics (16 papers), Cancer-related molecular mechanisms research (8 papers) and MicroRNA in disease regulation (7 papers). Weijian Sun collaborates with scholars based in China, United States and Singapore. Weijian Sun's co-authors include Xian Shen, Mingdong Lu, Yuanjin Zhao, Pihong Li, Zhiqiang Zheng, Qingfei Zhang, Yongdong Yi, Xiaohong Chen, Hui Zhang and Yingpeng Huang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Weijian Sun

79 papers receiving 1.6k citations

Hit Papers

Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cupr... 2024 2026 2025 2024 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijian Sun China 24 719 482 274 195 191 84 1.6k
Haitao Zhang China 21 710 1.0× 280 0.6× 209 0.8× 201 1.0× 174 0.9× 87 1.5k
Chengzhang Li China 25 682 0.9× 642 1.3× 256 0.9× 203 1.0× 198 1.0× 70 1.9k
Tingting Luo China 26 777 1.1× 524 1.1× 238 0.9× 426 2.2× 174 0.9× 106 2.0k
Qi Quan China 22 484 0.7× 302 0.6× 278 1.0× 219 1.1× 269 1.4× 94 1.7k
Yu Yao China 24 743 1.0× 430 0.9× 326 1.2× 300 1.5× 378 2.0× 62 1.6k
Jiyoon Bu South Korea 21 666 0.9× 476 1.0× 251 0.9× 149 0.8× 297 1.6× 51 1.4k
Wenjuan Ma China 26 1.0k 1.4× 454 0.9× 200 0.7× 182 0.9× 111 0.6× 53 1.9k
Mei Zhang China 25 966 1.3× 265 0.5× 306 1.1× 169 0.9× 256 1.3× 54 1.8k
Min Wu China 23 967 1.3× 412 0.9× 431 1.6× 85 0.4× 175 0.9× 92 1.9k
Lu Han China 17 550 0.8× 353 0.7× 203 0.7× 277 1.4× 244 1.3× 50 1.2k

Countries citing papers authored by Weijian Sun

Since Specialization
Citations

This map shows the geographic impact of Weijian Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijian Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijian Sun more than expected).

Fields of papers citing papers by Weijian Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijian Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijian Sun. The network helps show where Weijian Sun may publish in the future.

Co-authorship network of co-authors of Weijian Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Weijian Sun. A scholar is included among the top collaborators of Weijian Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijian Sun. Weijian Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Jingwei, Dongze Wu, Xinxin Yang, et al.. (2025). Safety and feasibility of novel single-port robotic systems in colorectal cancer surgery: a comparative study with the da Vinci Xi system. International Journal of Colorectal Disease. 40(1). 236–236.
3.
Deng, Wenhai, Shuaibin Wang, Yongyong Lu, et al.. (2025). Hyaluronic acid-modified doxorubicin-covalent organic framework nanoparticles triggered pyroptosis in combinations with immune checkpoint blockade for the treatment of breast cancer. International Journal of Biological Macromolecules. 310(Pt 3). 143265–143265. 2 indexed citations
4.
Yang, Xinxin, et al.. (2025). Robotic gastrointestinal surgery using the Weigao surgical robot system: a single-center prospective analysis. International Journal of Surgery. 111(12). 9363–9371.
5.
Yang, Nanfei, Qiang Tian, Shuxin Wang, et al.. (2025). FGF2 Mediated USP42‐PPARγ Axis Activation Ameliorates Liver Oxidative Damage and Promotes Regeneration. Advanced Science. 12(18). e2408724–e2408724.
6.
Sun, Weijian, et al.. (2024). A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation. Biochemical Pharmacology. 225. 116262–116262. 1 indexed citations
7.
Lu, Xufeng, Wenhai Deng, Shuaibin Wang, et al.. (2024). PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy. Materials Today Bio. 29. 101317–101317. 13 indexed citations
8.
Xiang, Zhichu, et al.. (2024). Engineering of a DNA/γPNA Hybrid Nanoreporter for ctDNA Mutation Detection via γPNA Urinalysis. Advanced Science. 11(33). e2310225–e2310225. 5 indexed citations
9.
Zhang, Qingfei, Gaizhen Kuang, Li Wang, et al.. (2024). Bio-inspired biorthogonal compartmental microparticles for tumor chemotherapy and photothermal therapy. Journal of Nanobiotechnology. 22(1). 498–498. 5 indexed citations
10.
Yi, Yongdong, et al.. (2024). Pyroptosis-related gene signature for predicting gastric cancer prognosis. Frontiers in Oncology. 14. 1336734–1336734. 2 indexed citations
11.
Yang, Nanfei, Bing Chen, Yuncheng Bei, et al.. (2023). A novel mesenchymal stem cell-based regimen for acute myeloid leukemia differentiation therapy. Acta Pharmaceutica Sinica B. 13(7). 3027–3042. 12 indexed citations
13.
Yan, Jiaqi, Xiaodong Ma, Meixin Ran, et al.. (2023). An autocatalytic multicomponent DNAzyme nanomachine for tumor-specific photothermal therapy sensitization in pancreatic cancer. Nature Communications. 14(1). 6905–6905. 97 indexed citations
14.
Zhang, Qingfei, et al.. (2023). Application of gas molecules in cancer therapy. SHILAP Revista de lepidopterología. 6. 46–60. 15 indexed citations
15.
Chen, Xiang, et al.. (2023). Suspended bubble microcapsule delivery systems from droplet microfluidic technology for the local treatment of gastric cancer. Chemical Engineering Journal. 458. 141428–141428. 20 indexed citations
16.
Kuang, Gaizhen, et al.. (2023). Near‐infrared light‐responsive Nitric oxide microcarrier for multimodal tumor therapy. SHILAP Revista de lepidopterología. 2(3). e20230016–e20230016. 9 indexed citations
17.
Wei, Xiaowei, Lijun Cai, Hanxu Chen, et al.. (2022). Noninvasive Multiplexed Analysis of Bladder Cancer-Derived Urine Exosomes via Janus Magnetic Microspheres. Analytical Chemistry. 94(51). 18034–18041. 17 indexed citations
18.
Huang, Liping, Changshun Xu, Yu Cai, et al.. (2022). Noninvasive Diagnosis of Gastric Cancer Based on Breath Analysis with a Tubular Surface-Enhanced Raman Scattering Sensor. ACS Sensors. 7(5). 1439–1450. 76 indexed citations
19.
Sun, Weijian, Jiucheng Zhang, Xinglong Ji, et al.. (2021). Low nitrate alleviates iron deficiency by regulating iron homeostasis in apple. Plant Cell & Environment. 44(6). 1869–1884. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026